Remove Healthcare Remove IPO Remove S&P
article thumbnail

Covid-19 and US Venture Capital in 2020

InvestmentBank.com

Second, the IPO market, a key exit avenue for VC investments, proved increasingly strong and resilient throughout the year. These were just a few of many strong IPOs seen this year. As of December 23rd, 2020, US stock markets saw 477 IPOs, more than doubling the 233 IPOs from 2019, at least 120 of which were venture-backed [14] [11].

Capital 40
article thumbnail

Industrials Private Equity: The Best Place for Old-School Deals at Reasonable Multiples?

Mergers and Inquisitions

Today, you could put most private equity activity in industrials into a few main categories: Consolidation / Roll-Up Plays – The idea is to acquire smaller companies to consolidate the parent company’s market position and become more appealing in an eventual IPO or M&A deal. To illustrate a simple deal, let’s use CD&R’s ~$2.6

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Venture Capital Interview Questions: What to Expect and How to Prepare

Mergers and Inquisitions

You can also link this back to tech or healthcare companies you’ve advised or earlier-stage businesses where your work made a difference. Q: Tell me about the current IPO, M&A, and VC funding markets. Example answer: “ I would invest in Novoic, a healthcare IT startup in the U.K. It raised a $2.6

Capital 59
article thumbnail

Cooley’s 2021 Life Sciences M&A Year in Review

Cooley M&A

While 2020’s M&A landscape was characterized by whiplash volatility from choppy deal activity in the first half of the year to a surge in volume in the second half, that momentum accelerated in 2021, with no signs of slowing down heading into 2022. on transactions over 2019’s mega?mergers. General trends in life sciences M&A.

M&A 40